Showing 15 of 75 recruiting trials for “squamous-cell-carcinoma-of-the-esophagus”
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy
RecruitingNCT05126160 ↗
Immune Score Based Radiomics in Nasopharyngeal Carcinoma
👨⚕️ Xiaozhong Chen, Department of Radiation Oncology, Zhejiang Cancer Hospital📍 5 sites📅 Started Nov 2021View details ↗
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
👨⚕️ Jinquan Liu, M.D, Affiliated Cancer Hospital & Institute of Guangzhou Medical University📍 1 site📅 Started Aug 2020View details ↗
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
RecruitingNCT04547673 ↗
To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
👨⚕️ Weiping Wen, Ph.D, Otolaryngology Department, First Affiliated Hospital of Sun Yat-sen University📍 3 sites📅 Started Jun 2020View details ↗
RecruitingNCT04544969 ↗
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
RecruitingNCT04085900 ↗
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
👨⚕️ Mingfang Ji, MD, Zhongshan People's Hospital, Guangdong, China📍 2 sites📅 Started Apr 2020View details ↗
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
← PreviousPage 4 of 4
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →